Historical record - last NADAC publication: 2/19/2014
Product Information
MORPHINE SULFATE ER 30 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $3.7385 per EA under NDC 00832022750. Its NADAC has been published 15 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832022750
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
2/19/2014
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202104On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 30 MG CAP has been published 15 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7385 per EA |
|---|---|
| All-time high | $4.0176 (Jan 15, 2014) |
| All-time low | $3.7295 (Jan 22, 2014) |
| Median price | $3.7779 |
| Average price | $3.8370 |
| Largest weekly change | -7.2% (Jan 22, 2014) |
| Weeks tracked | 15 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 30 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $3.7385 per EA (NDC 00832022750), effective Mar 5, 2014.
How has the price of MORPHINE SULFATE ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 30 MG CAP has held within roughly two percent of its current level. It has been tracked across 15 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 30 MG CAP?
Since Nov 28, 2013, the NADAC for MORPHINE SULFATE ER 30 MG CAP has ranged from a low of $3.7295 (Jan 22, 2014) to a high of $4.0176 (Jan 15, 2014), with a median of $3.7779 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 30 MG CAP?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MORPHINE SULF ER 30 MG TABLET, is $0.3462 per EA — about 91% below MORPHINE SULFATE ER 30 MG CAP.
Who manufactures MORPHINE SULFATE ER 30 MG CAP?
MORPHINE SULFATE ER 30 MG CAP (NDC 00832022750) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification